Humanization of the rpb9 locus in fission yeast reveals conserved and divergent roles of rpb9 and human POLR2I

This study establishes an endogenous humanized fission yeast system to demonstrate that human POLR2I largely complements conserved and novel roles of yeast Rpb9 in growth, stress response, and heterochromatin assembly, while revealing specific context-dependent functional divergences in drug resistance.

The Gist

The Big Picture: Swapping Engines in a Car

Imagine a complex machine, like a high-performance race car. This car is a cell, and its engine is a massive molecular machine called RNA Polymerase II. This engine is responsible for reading the car's manual (DNA) and writing down instructions (RNA) so the car can function.

Inside this engine, there are 12 different parts (subunits). Most of these parts are essential; if you remove them, the car stops completely. However, one specific part, called Rpb9 (in yeast) or POLR2I (in humans), is a "nice-to-have" rather than a "must-have." The car can still run without it, but it runs poorly, especially when the road gets bumpy (stressful conditions).

Scientists have known a lot about the yeast version of this part (Rpb9) but very little about the human version (POLR2I). Since the human version is linked to diseases like cancer and drug resistance, understanding it is crucial.

The Experiment: The "Humanized" Yeast

The researchers wanted to see if the human part (POLR2I) could do the exact same job as the yeast part (Rpb9).

The Old Way (The Problem):
Previously, scientists tried to test this by sticking the human part into a yeast cell using a "plasmid" (a tiny, extra piece of DNA).

• The Analogy: Imagine trying to fix a Ferrari by duct-taping a Toyota engine part onto the dashboard. It might work if you tape it on really tight (high expression), but it's not how the car was designed. The engine might run weirdly, or the part might not fit right because it's being forced into a spot it doesn't belong.

The New Way (The Solution):
In this study, the team used a "genome editing" technique to permanently swap the yeast's native Rpb9 gene with the human POLR2I gene.

• The Analogy: Instead of duct-taping a Toyota part to the dashboard, they took the old Toyota engine out of the garage and installed a brand-new, custom-built human engine directly into the engine block where the original belonged. They even rewired the fuel lines (codon-optimization) so the human part could speak the yeast's language.

What They Found: The "Human" Engine Works (Mostly)

They put these "humanized" yeast cars on the track and tested them under various conditions.

1. The Conserved Roles (Where the Human Part Shined)
In many scenarios, the human part worked just as well as the yeast part.

• Growth & Aging: The yeast grew normally and lived a long life, just like the wild-type yeast.
• Stress Tests: When they threw salt (NaCl) or antifungal drugs (Thiabendazole) at the yeast, the humanized yeast survived.
• Chemotherapy Resistance: They tested a common chemo drug (5-Fluorouracil). The human part helped the yeast resist it, suggesting that the human version of this protein plays a role in how cancer cells might resist chemotherapy.
• The "Heterochromatin" Mystery: They discovered a new job for this part. It helps organize the "junk drawer" of the cell's DNA (facultative heterochromatin). The human part could do this job perfectly, meaning this ancient mechanism is conserved across billions of years of evolution.

2. The Divergent Role (Where the Human Part Stumbled)
There was one specific test where the human part failed.

• The 6-AU Test: They exposed the yeast to a drug called 6-azauracil (6-AU), which slows down the engine's writing speed.
• The Result: The yeast with the human part died. The yeast with the yeast part survived.
• The Twist: However, when they went back to the "old way" (duct-taping the human part onto the dashboard with high expression), it did work.
• The Takeaway: This suggests that the human part can do the job, but only if it's present in huge amounts. In its natural, "installed" state, it's not quite strong enough to handle this specific stress. This reveals a subtle difference between how yeast and humans regulate this protein.

The Structural Check: Are They Twins?

The researchers looked at the 3D shapes of the proteins using computer models (AlphaFold).

• The Analogy: They compared the blueprints of the yeast part and the human part. They are 47% identical in their amino acid sequence.
• The Verdict: The shapes are remarkably similar (like two different models of the same car brand). They fit into the main engine block in almost the exact same way. However, the human part has a slightly longer "tail" at the front and a small extra loop in the middle. These tiny differences might be why it struggles with the 6-AU drug.

Why Does This Matter?

1. Better Science: This study proves that swapping genes directly into the genome (rather than using plasmids) gives us a much clearer, more accurate picture of how human genes work.
2. Cancer Clues: Since the human part (POLR2I) helps yeast resist certain drugs, this might explain why some human cancers are resistant to chemotherapy. If we understand how this protein works, we might find new ways to stop cancer cells from fighting back.
3. Evolution: It shows that while the core machinery of life is ancient and shared, nature has tweaked the human version slightly to handle different challenges.

In Summary:
The researchers took a yeast cell, replaced its "spare tire" (Rpb9) with a human spare tire (POLR2I), and found that the human tire works great on most roads. However, on a specific, bumpy road (6-AU stress), the human tire needs a little extra air pressure (higher expression) to keep the car moving. This simple swap revealed deep secrets about how our cells work and how they might fail in disease.

Technical Summary

1. Problem Statement

RNA Polymerase II (Pol II) is essential for gene regulation, with its subunit POLR2I (known as Rpb9 in yeast) playing critical roles in transcription fidelity, elongation, and DNA repair. While the functions of yeast Rpb9 are well-characterized, the molecular roles of its human homolog, POLR2I, remain poorly understood. Recent studies link POLR2I dysregulation to human pathologies, including cancer chemoresistance and metastasis.

Previous attempts to study POLR2I function using ectopic expression (plasmid-based overexpression) in yeast (Saccharomyces cerevisiae and Schizosaccharomyces pombe) yielded conflicting results. High-level expression sometimes rescued phenotypes while low-level expression did not, suggesting that non-physiological expression levels and the disruption of native regulatory contexts (promoters, UTRs, introns) confounded the interpretation of functional conservation. There was a need for a more physiologically relevant model to distinguish between conserved and divergent functions of Rpb9 and POLR2I.

2. Methodology

The authors developed a genomic endogenous humanization strategy in the fission yeast Schizosaccharomyces pombe to replace the native rpb9 gene with the human POLR2I gene.

• Genomic Engineering:
  • Utilized a two-step, scarless homologous recombination approach to swap the endogenous rpb9 open reading frame (ORF) with the human POLR2I ORF.
  • Codon Optimization: The human POLR2I sequence was codon-optimized for S. pombe to ensure efficient translation.
  • Intron Removal: The human POLR2I gene (which contains five introns) was synthesized as an intronless sequence, as S. pombe splicing mechanisms differ from humans, and the goal was to test protein function rather than splicing compatibility.
  • Regulatory Context: The humanized gene was integrated at the native rpb9 locus, preserving the endogenous promoter, 5' and 3' untranslated regions (UTRs), and flanking sequences.
• Validation:
  • Confirmed integration via PCR and Sanger sequencing.
  • Verified protein expression and nuclear localization using C-terminal GFP tagging and Western blotting.
• Functional Assays:
  • Growth & Aging: Measured growth rates in rich media (YEA) and chronological lifespan (viability in stationary phase).
  • Stress Response: Tested sensitivity to environmental stressors (NaCl), chemotherapy (5-fluorouracil/5-FU), antifungals (thiabendazole/TBZ), and transcription elongation inhibitors (6-azauracil/6-AU).
  • Chromatin Analysis: Performed Chromatin Immunoprecipitation (ChIP) to assess H3K9me2 levels (a marker for facultative heterochromatin) at specific loci (mei4 and ssm4).
  • Structural Analysis: Compared protein structures using AlphaFold predictions and empirical PDB structures (3H0G for Rpb9, 9EHZ for POLR2I), calculating TM-scores and RMSD.

3. Key Contributions

• Novel Complementation Strategy: Established a robust "humanized yeast" system where the human gene is expressed under native yeast regulatory control, eliminating variables associated with plasmid-based overexpression.
• Discovery of Conserved Roles: Identified previously unrecognized conserved functions of Rpb9/POLR2I in facultative heterochromatin assembly and resistance to specific chemotherapeutics.
• Identification of Divergent Roles: Demonstrated that while POLR2I is highly conserved, it exhibits context-dependent functional divergence, specifically failing to complement resistance to the transcription elongation inhibitor 6-AU under endogenous expression conditions.

4. Key Results

• Protein Expression & Localization: The endogenously expressed, codon-optimized POLR2I protein was successfully produced in S. pombe. While expression levels were modestly lower than native Rpb9, the protein correctly localized to the nucleus, consistent with its role as a Pol II subunit.
• General Growth & Aging: The rpb9Δ::POLR2I strain largely rescued the growth defects and chronological aging defects observed in rpb9Δ null mutants, indicating strong functional conservation in general cellular physiology.
• Stress Resistance (Conserved):
  • 5-FU & TBZ: Human POLR2I fully complemented the hypersensitivity of rpb9Δ cells to the chemotherapy drug 5-fluorouracil and the fungicide thiabendazole.
  • NaCl: POLR2I restored resistance to high salt concentrations (150 mM NaCl).
• Heterochromatin Formation (Novel Conservation):
  • rpb9Δ cells showed a loss of H3K9me2 marks at facultative heterochromatin loci (mei4, ssm4).
  • Expression of human POLR2I restored H3K9me2 levels, revealing a conserved role for Rpb9/POLR2I in Mmi1-dependent heterochromatin assembly.
  • This rescue was dependent on the methyltransferase Clr4, as rpb9Δ::POLR2I clr4Δ double mutants remained sensitive to TBZ.
• 6-AU Resistance (Divergence):
  • Unlike other stressors, endogenous POLR2I failed to rescue the hypersensitivity of rpb9Δ cells to 6-azauracil (6-AU), a drug that inhibits transcription elongation.
  • Context Dependence: When POLR2I was expressed ectopically from a plasmid (high expression), it did rescue the 6-AU sensitivity. This suggests that the inability of endogenous POLR2I to function in this specific context may be due to subtle differences in protein levels, structural nuances (e.g., the N-terminal tail of POLR2I), or yeast-specific regulatory mechanisms.
• Structural Conservation:
  • Sequence identity: ~51% (DNA) and ~47% (Amino Acid).
  • Structural similarity: High TM-scores (0.84 for AlphaFold models, 0.79 for empirical structures).
  • Both proteins show nearly identical interaction interfaces with the core Pol II subunits (Rpb1 and Rpb2), though POLR2I possesses a unique N-terminal extension and a small insertion in the second zinc finger domain.

5. Significance

This study provides a critical advancement in understanding the evolutionary conservation of the Pol II machinery. By moving beyond plasmid-based overexpression, the authors demonstrated that:

1. Functional Conservation is Broad: Human POLR2I can largely replace yeast Rpb9 in essential cellular processes, including stress response and chromatin regulation.
2. New Biological Insights: The link between Rpb9/POLR2I and facultative heterochromatin formation (via H3K9me2) is a novel discovery with implications for understanding gene silencing mechanisms in humans.
3. Context Matters: The failure to complement 6-AU resistance under endogenous conditions highlights that functional conservation is not absolute; it can be phenotype-specific and dependent on precise expression levels or structural context.
4. Clinical Relevance: Validating the conserved roles of POLR2I in chemoresistance (5-FU) and heterochromatin regulation offers new avenues for investigating the molecular basis of human diseases where POLR2I is dysregulated, such as colorectal cancer and hypertensive nephropathy.

The study establishes a refined framework for cross-species gene complementation, proving that endogenous replacement is a superior method for dissecting the nuanced functional relationships between yeast and human homologs.